Cornerstone Capital Management Holdings’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-183,398	Closed	-$1.65M	–	1507
2016 Q3	$1.65M	Sell	183,398 -248,403	-58%	-$1.77M	0.01%	820
2016 Q2	$2.32M	Buy	431,801 +19,700	+5%	+$101K	0.02%	692
2016 Q1	$1.9M	Buy	412,101 +160,298	+64%	+$644K	0.02%	760
2015 Q4	$1.31M	Buy	251,803 +191,703	+319%	+$1.11M	0.01%	832
2015 Q3	$363K	Sell	60,100 -48,200	-45%	-$591K	﹤0.01%	1092
2015 Q2	$1.71M	Buy	108,300 +106,300	+5,315%	+$1.29M	0.02%	764
2015 Q1	$22K	Sell	2,000 -4,800	-71%	-$49K	﹤0.01%	1339
2014 Q4	$72K	Buy	+6,800	New	+$66.4K	﹤0.01%	1192

Cornerstone Capital Management Holdings's RPTP Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 183,398 shares — an estimated $1.65M sold.

Cornerstone Capital Management Holdings first reported a position in RPTP in Q4 2014 and held it in 8 quarters. The position peaked at $2.32M in Q2 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 183,398 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.65M.
Cornerstone Capital Management Holdings first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 8 quarters.
Cornerstone Capital Management Holdings's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.32M in Q2 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.